Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2026-01-07 @ 2:15 AM
Study NCT ID:
NCT02655458
Status:
COMPLETED
Last Update Posted:
2017-08-18
First Post:
2016-01-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma
Sponsor:
Hearn Jay Cho
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
None
Primary Completion Date:
2017-07-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-07-13
Completion Date Type:
ACTUAL
First Submit Date:
2016-01-12
First Submit QC Date:
None
Study First Post Date:
2016-01-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-08-15
Last Update Post Date:
2017-08-18
Last Update Post Date Type:
ACTUAL